The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
Scientists at @HopkinsMedicine say they found a class of inhibitors that may lead to better, more effective treatments for ...
Morning Overview on MSN
A common blood-pressure pill mixed with a routine antibiotic can trigger kidney injury
Patients who take a calcium-channel blocker for high blood pressure and then receive a prescription for clarithromycin, one ...
Two professors from Washington State University have designed a dietary supplement meant to ease the addictive nature of nicotine and restrict the negative effects air pollutants have on the body.
Some healthy-looking foods and common pantry staples may interfere with blood pressure medications, potentially reducing ...
CureGene Pharmaceutical today announced that the first participant has been successfully dosed in the U.S. pivotal clinical trial of Evategrel (CG-0255), its proprietary new-generation best-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results